Indications And Dose
Raised intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension when beta-blocker or prostaglandin analogue alone not adequate ▶TO THE EYE ▶Adult: Apply once daily
PDF page 1272
Drug reference
Raised intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension when beta-blocker or prostaglandin analogue alone not adequate ▶TO THE EYE ▶Adult: Apply once daily
PDF page 1272
GANFORT ® SINGLE USE Scottish Medicines Consortium (SMC) decisions The Scottish Medicines Consortium has advised (October 2013) that Ganfort ® unit dose eye drops are accepted for restricted use within NHS Scotland for the reduction of intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension insufficiently responsive to topical beta-blockers or prostaglandin analogues who have proven sensitivity to preservatives.
PDF page 1272
→Appendix 1: beta blockers, non-selective
PDF page 1272
There can be variation in the licensing of different medicines containing the same drug. Eye drops EXCIPIENTS: May contain Benzalkonium chloride ▶Eyzeetan (Aspire Pharma Ltd) Bimatoprost 300 microgram per 1 ml,Timolol (as Timolol maleate) 5 mg per 1 ml Eyzeetan 0.3mg/ml / 5mg/ml eye drops | 3 ml P £14.16 DT = £14.16 ▶Ganfort (Allergan Ltd) Bimatoprost 300 microgram per 1 ml,Timolol (as Timolol maleate) 5 mg per 1 ml Ganfort 0.3mg/ml / 5mg/ml eye drops | 3 ml P £14.16 DT = £14.16 | 9 ml P £38.15 Ganfort 0.3mg/ml / 5mg/ml eye drops 0.4ml unit dose | 30 unit dose P £17.94 DT = £17.94 SYMPATHOMIMETICS › ALPHA2-ADRENOCEPTOR AGONISTS
PDF pages 1272, 1273
Apply once daily
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1272